Mohammad Hosein Farzaei

Mohammad Hosein Farzaei

Auto-generated profile, based on publicly available information

Mohammad Hosein Farzaei

Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2023 in Phytomedicine
Verified
Journal Article
Closed access
MGMohammad Mehdi Gravandi
Mohammad Mehdi Gravandi
SASadaf Abdian
Sadaf Abdian
MTMaedeh Tahvilian
Maedeh Tahvilian
Amin IranpanahAmin Iranpanah
Amin Iranpanah
Seyed Zachariah MoradiSeyed Zachariah Moradi
Seyed Zachariah Moradi
Javier EcheverríaJavier Echeverría
Javier Echeverría

26 February 2025 in Jundishapur Journal of Natural Pharmaceutical Products
Verified
Journal Article
Open access
MGmohammad mehdi gravandi
mohammad mehdi gravandi
HAHanieh Alidoust
Hanieh Alidoust
MTMaedeh Tahvilian
Maedeh Tahvilian
EMElnaz Moradi
Elnaz Moradi
MHMohammad Hashemnia
Mohammad Hashemnia
MFMohammad Hosein Farzaei
Mohammad Hosein Farzaei
Background: Inflammatory bowel disease (IBD) encompasses chronic gastrointestinal conditions such as Crohn's disease and ulcerative colitis (UC). Despite their differing pathophysiologies, these conditions are influenced by common factors, including genetics, environmental influences, and gut microbiota. Recent studies suggest that oxidative stress significantly contributes to intestinal inflammation. Additionally, medicinal plants are recognized for their efficacy in treating various illnesses, forming the basis of many modern medications. Objectives: This study investigated the potential of rutin, a natural compound, by synthesizing it into nanoparticles. These rutin nanoparticles were designed to enhance drug solubility and intestinal absorption, thereby improving therapeutic efficacy and shelf life. Methods: Thirty adult rats were divided into six groups for this experiment. Excluding the control group, all were treated with 2 mL of 4% acetic acid (AA) followed by sulfasalazine. Subsequently, three different dosages of rutin nanoparticles (100, 150, and 200 mg/kg) were administered. The evaluation included tests for glutathione (GSH), nitric oxide (NO), superoxide dismutase (SOD), and tumor necrosis factor-alpha (TNF-α), as well as macroscopic and microscopic analyses. Results: Intracolonic administration of AA resulted in severe acute inflammation in the colonic tissue, which was improved by rutin nanoparticles in both microscopic and macroscopic aspects. Additionally, rutin nanoparticles modified TNF-α and oxidative stress-related markers, including GSH, NO, and SOD levels. Conclusions: Our results indicate that rutin nanoparticles exhibit significant therapeutic effects in treating UC. These findings suggest the potential of natural products and their nanoparticle formulations in treating inflammatory diseases.

6 April 2025 in Jundishapur Journal of Natural Pharmaceutical Products
Verified
Journal Article
Open access
SAShirin Asar
Shirin Asar
MGmohammad mehdi gravandi
mohammad mehdi gravandi
HKHosna Khazaei
Hosna Khazaei
SFSajad Fakhri
Sajad Fakhri
Amin IranpanahAmin Iranpanah
Amin Iranpanah
MFMohammad Hosein Farzaei
Mohammad Hosein Farzaei
Background: Rheumatoid arthritis (RA) is a persistent inflammatory condition characterized by an imbalance in oxidative stress and chronic inflammation of joint tissues. Objectives: Fraxinus excelsior L., commonly known as ash, has demonstrated anti-inflammatory, antioxidant, immunomodulatory, and neuroprotective properties. The present study aims to evaluate the therapeutic effects of F. excelsior L. bark hydromethanolic extract (FEE) in the management of RA. Methods: Thirty male rats were randomly divided into six groups: Normal control, RA, three dosages of FEE (20, 40, 80 mg/kg/day, orally), and prednisolone (10 mg/kg/day, orally). These doses were selected to evaluate the potential dose-dependent effects of FEE. The hot plate test, serum glutathione (GSH), malondialdehyde (MDA), and histopathological investigations were assessed. The activity of matrix metalloproteinases (MMP-2 and MMP-9) was measured using zymography. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis previously confirmed the presence of coumarins in FEE. Results: The FEE significantly reduced pain perception in the hot plate test (P < 0.001). Malondialdehyde levels were significantly elevated in RA rats (P < 0.001) but were reduced following FEE and prednisolone treatment (P < 0.01). Similarly, GSH levels were significantly decreased in RA rats (P < 0.001) but were restored in FEE-treated groups (P < 0.01, P < 0.001 for higher doses). The FEE also significantly decreased MMP-2 and MMP-9 activity (P < 0.001), confirming its anti-inflammatory potential. Histopathological analyses corroborated these findings, demonstrating reduced synovial hyperplasia and inflammatory cell infiltration in FEE-treated groups. Coumarins in FEE are known to modulate inflammation through inhibition of MMP-2 and MMP-9 activity and regulate oxidative stress by enhancing antioxidant defenses, including increasing GSH levels and reducing MDA accumulation. Conclusions: Given the improvements in behavioral, biochemical, and histopathological parameters alongside modulation of inflammation (MMP-2, MMP-9) and oxidative stress (MDA, GSH), our results suggest that FEE, rich in coumarins, could be a promising candidate for RA management.

21 July 2025 in Jundishapur Journal of Natural Pharmaceutical Products
Verified
Journal Article
Open access
MGmohammad mehdi gravandi
mohammad mehdi gravandi
PKPershia Davoodi Karsalari
Pershia Davoodi Karsalari
SSSamira Shirooie
Samira Shirooie
MTMaedeh Tahvilian
Maedeh Tahvilian
MFMohammad Hosein Farzaei
Mohammad Hosein Farzaei
Background: Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic condition affecting women during their reproductive years, often characterized by symptoms such as acne, hirsutism, alopecia, and seborrheic dermatitis. The development of the condition is linked to disturbances in hormonal production, maturation of ovarian follicles, regulation of neuroendocrine signals, metabolic pathways, insulin action and resistance, adipose tissue function, inflammatory mechanisms, and the stability of the autonomic nervous system. Tragopogon graminifolius DC (Sheng plant) exhibits both anti-inflammatory and antioxidant effects, and prior studies have indicated its potential to reduce glucose, cholesterol, and triglyceride levels. Objectives: This research investigates how a hydroalcoholic extract derived from the Sheng plant influences PCOS induced by testosterone in a rat model. Methods: Twenty-five young female Wistar rats were evenly distributed into five experimental groups using a randomization method: (1) Healthy control, (2) PCOS model, (3) metformin-treated, (4) Sheng extract at 100 mg/kg, and (5) Sheng extract at 200 mg/kg. The PCOS was induced using the androgenized rodent model. After completing the regimen, the rats were subjected to anesthesia, and blood was drawn to assess hormone levels and blood glucose concentrations. Ovarian tissues were also examined histopathologically. Results: The hydroalcoholic extract of the Sheng plant reduced testosterone and luteinizing hormone (LH) levels while increasing follicle-stimulating hormone (FSH) levels. Blood glucose concentrations declined following treatment. Histopathological analysis revealed normalization of granulosa cells and the presence of mature follicles with intact granulosa layers in the treated groups. In general, the administration of Sheng extract at both low (100 mg/kg) and high (200 mg/kg) doses significantly contributed to the restoration of sex hormone balance and improvement of ovarian structure. Conclusions: The findings suggest that the hydroalcoholic extract of the Sheng plant may have a therapeutic role in improving PCOS by modulating sex hormone levels and restoring ovarian function. Further studies are warranted to explore its clinical applicability.

1 January 2026 in Journal of Food Biochemistry
Verified
Journal Article
Open access
MGMohammad Mehdi Gravandi
Mohammad Mehdi Gravandi
DEDaniel Elieh-Ali-Komi
Daniel Elieh-Ali-Komi
RARoshanak Amirian
Roshanak Amirian
SHSeyede Zahra Hosseini
Seyede Zahra Hosseini
SASeyede Darya Alavi
Seyede Darya Alavi
MFMohammad Hosein Farzaei
Mohammad Hosein Farzaei
Background: The extract of Ailanthus altissima possesses anti‐inflammatory and neuroprotective properties. We aimed to investigate its effectiveness in mitigating the AlCl 3 ‐induced Alzheimer’s disease in a rat model. Methods: A total of 32 adult male Wistar rats were divided into 4 groups each consisting of 8 rats. The control group received saline and the AlCl 3 group received AlCl 3 (0.2 cc 100 mg/kg, intraperitoneal) for 14 days. Two other groups received either 50 or 100 mg/kg of Ailanthus altissima after AlCl 3 treatment. Behavioral tests including open field test (OFT), elevated plus maze, and passive avoidance tests were performed. Nuclear factor kappa B (NF‐κB), glial filamentous acidic protein (GFAP), and amyloid beta were stained using immunohistochemistry (IHC) in the hippocampus. Results: AlCl 3 administration caused significant memory impairment, and treatment with Ailanthus altissima extract effectively mitigated these deficits in a dose‐dependent manner. The effects were dose‐dependent, and the group receiving 100 mg/kg extract presented the most significant results in the conducted behavioral tests. The IHC results for NF‐κB showed that treatment with 50 mg/kg of extract significantly reduced NF‐κB expression compared with the AlCl 3 group (6.64% vs. 13.3%, respectively, p < 0.05). A higher dose of 100 mg/kg resulted in an even greater reduction (4.45% vs. 13.3%, p < 0.01). Extract treatment reduced GFAP positivity in a dose‐dependent manner, with the 50 mg/kg group showing a significant decrease to 11.8% ( p < 0.05). The 100 mg/kg group demonstrated an even more substantial reduction to 7.7% ( p < 0.01) compared with the AlCl 3 group (18.65%). Amyloid beta positivity was critically reduced in the 100 mg/kg‐receiving group. Conclusions: Ailanthus altissima extract shows potential as a neuroprotective extract. It counteracts AlCl 3 ‐induced behavioral and neuropathological changes, suggesting promising therapeutic applications.